Prenatal typing of Rh and Kell blood group system antigens: The edge of a watershed

Transfusion Medicine Reviews

Volumn 17, Issue 1, 2003, Pages 31-44

  Van der Schoot, C Ellen ^a,b,c,d   Tax, G H Martine ^a,b,c   Rijnders, Robbert J P ^a,b,c   De Haas, Masja ^a,b,c   Christiaens, Godelieve C M L ^a,b,c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d CENTRAL LABORATORY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; RHESUS ANTIGEN;

BIOASSAY; BIOAVAILABILITY; BLOOD GROUP KELL SYSTEM; BLOOD GROUP RHESUS SYSTEM; BLOOD GROUP SYSTEM; CELL FREE SYSTEM; CHORION VILLUS SAMPLING; COST EFFECTIVENESS ANALYSIS; DELIVERY; FETUS CELL; FIRST TRIMESTER PREGNANCY; GENOTYPE; HUMAN; MOLECULAR BIOLOGY; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; PROPHYLAXIS; REVIEW; THIRD TRIMESTER PREGNANCY; VALIDATION PROCESS; WATERSHED; ZYGOSITY;

EID: 0037225919     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1053/tmrv.2003.50001     Document Type: Review

References (119)

1. van Kamp IL, Klumper FJ, Meerman RH, et al: Blood group immunization: results of treatment of fetal anemia with intra-uterine intravascular blood transfusion in the Netherlands, 1987-1995. Ned Tijdschr Geneeskd 143:2527-2531, 1999
2. Nicolaides KH, Rodeck CH: Maternal serum anti-D anti-body concentration and assessment of rhesus isoimmunisation. BMJ 304:1155-1156, 1992
3. Oepkes D, van Kamp IL, Simon MJ, et al: Clinical value of an antibody-dependent cell-mediated cytotoxicity assay in the management of Rh D alloimmunization. Am J Obstet Gynecol 184:1015-1020, 2001
4. Gemke RJ, Kanhai HH, Overbeeke MA, et al: ABO and Rhesus phenotyping of fetal erythrocytes in the first trimester of pregnancy. Br J Haematol 64:689-697, 1986
5. + transporters. Trends Biochem Sci 22:460-461, 1997
6. Marini A-M, Matassi G, Raynal V, et al: The human Rhesus-associated RhAG protein and a kidney homologue promote ammonium transport in yeast. Nat Genet 26:341-344, 2000
7. Colin Y, Cherif-Zahar B, Le Van Kim C, et al: Genetic basis of the RhD-positive and RhD-negative blood group polymorphism as determined by Southern analysis. Blood 78:2747-2752, 1991
8. Wagner FF, Flegel WA: RHD gene deletion occurred in the Rhesus box. Blood 95:3662-3668, 2000
9. Avent ND, Reid ME: The Rh blood group system: A review. Blood 95:375-387, 2000
10. Faas BHW, Beckers EAM, Wildoer P, et al: Molecular background of VS and weak C expression in blacks. Transfusion 37:38-44, 1997
11. Singleton BK, Green CA, Avent ND, et al: The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in africans with the Rh D-negative blood group phenotype. Blood 95:12-18, 2000
12. Tax GHM, van der Schoot CE, van Doorn R, et al: Rhesus C and c genotyping in different ethnic groups. Transfusion (in press)
13. Wagner FF, Frohmajer A, Flegel WA: RHD Positive Haplotypes in D Negative Europeans. Available at: http://www. biomedcentral.com/1471-2156/2/10. Accessed October 1, 2002
14. Okuda H, Kawano M, Iwamoto S, et al: The RHD gene is highly detectable in RhD-negative Japanese donors. J Clin Invest 100:373-379, 1997
15. Hemker MB, Ligthart PC, Berger L, et al: DAR, a new RhD variant involving exons 4, 5 and 7, often in linkage with ceAR, a new Rhce variant frequently found in African blacks. Blood 94:4337-4342, 1999
16. Wolter LC, Hyland CA, Saul A: Rhesus D genotyping using polymerase chain reaction. Blood 82:1682-1683, 1993
17. Bennett PR, Le Van Kim C, Colin Y, et al: Prenatal determination of fetal RhD type by DNA amplification. N Engl J Med 329:607-610, 1993
18. Arce MA, Thompson ES, Wagner S, et al: Molecular cloning of RhD cDNA derived from a gene present in RhD-positive, but not RhD-negative individuals. Blood 82:651-655, 1993
19. Simsek S, Bleeker PM, von dem Borne AE: Prenatal determination of fetal RhD type. N Engl J Med 330:795-796, 1994
20. Simsek S, Faas BH, Bleeker PM, et al: Rapid Rh D genotyping by polymerase chain reaction-based amplification of DNA. Blood 85:2975-2980, 1995
21. Pope J, Navarrete C, Warwick R, et al: Multiplex PCR analysis of RhD gene. Lancet 346:375-376, 1995
22. Aubin JT, Le Van Kim C, Mouro I, et al: Specificity and sensitivity of RHD genotyping methods by PCR-based DNA amplification. Br J Haematol 98:356-364, 1997
23. Gassner C, Schmarda A, Kilga-Nogler S, et al: RHD/CE typing by polymerase chain reaction using sequence-specific primers. Transfusion 37:1020-1026, 1997
24. Maaskant-van Wijk PA, Faas BH, de Ruijter JA, et al: Genotyping of RHD by multiplex polymerase chain reaction analysis of six RHD-specific exons. Transfusion 38:1015-1021, 1998
25. Legler TJ, Maas JH, Kohler M, et al: RHD sequencing: A new tool for decision making on transfusion therapy and provision of Rh prophylaxis. Transfus Med 11:383-388, 2001
26. Lo YM, Hjelm NM, Fidler C, et al: Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 339:1734-1738, 1998
27. Avent ND, Finning KM, Martin PG, et al: Prenatal determination of fetal blood group status. Vox Sang 78:155-162, 2000 (suppl)
28. Zhong XY, Holzgreve W, Hahn S: Risk free simultaneous prenatal identification of fetal Rhesus D status and sex by multiplex real-time PCR using cell free fetal DNA in maternal plasma. Swiss Med Wkly 131:70-74, 2001
29. Heid CA, Stevens J, Livak KJ, et al: Real time quantitative PCR. Genome Res 6:986-994, 1996
30. Kemp TJ, Poulter M, Carritt B: Microsatellite variation within the human RHCE gene. Vox Sang 77:159-163, 1999
31. Huang CH, Reid ME, Chen Y, et al: Molecular definition of red cell Rh haplotypes by tightly linked Sphl RFLPs. Am J Hum Genet 58:133-142, 1996
32. Fujiwara H, Okuda H, Omi T, et al: The STR polymorphisms in intron 8 may provide information about the molecular evolution of RH haplotypes. Hum Genet 104:301-306, 1999
33. Chan FY, Cowley NM, Wolter L, et al: Prenatal RHD gene determination and dosage analysis by PCR: Clinical evaluation. Prenat Diagn 21:321-326, 2001
34. Cossu G, Angius A, Gelfi C, et al: Rh D/d genotyping by quantitative polymerase chain reaction and capillary zone electrophoresis. Electrophoresis 17:1911-1915, 1996
35. Chiu RW, Murphy MF, Fidler C, Wainscoat JS, et al: Technical optimization of RhD zygosity determination by real-time quantitative polymerase chain reaction: Implication for fetal RhD status determination by maternal plasma. Ann N Y Acad Sci 945:156-160, 2001
36. Chiu RW, Murphy MF, Fidler C, et al: Determination of RhD zygosity: Comparison of a double amplification refractory mutation system approach and a multiplex real-time quantitative PCR approach. Clin Chem 47:667-672, 2001
37. Mouro I, Colin Y, Cherif-Zahar B, et al: Molecular genetic basis of the human Rhesus blood group system. Nat Genet 5:62-65, 1993
38. Simsek S, de Jong CAM, Cuijpers HM, et al: Sequence analysis of cDNA derived from reticulocyte mRNAs coding for Rh polypeptides and demonstration of E/e and C/c polymorphisms. Vox Sang 67:203-209, 1994
39. Poulter M, Kemp TJ, Carrit B: DNA-based Rhesus typing: Simultaneous determination of the RHC and RHD status using the polymerase chain reaction. Vox Sang 70:164-168, 1996
40. Salvignol I, Calvas P, Socha WW, et al: Structural analysis of the RH-like blood group gene products in nonhuman primates. Immunogenetics 41:271-281, 1995
41. Westhoff CM, Silberstein LE, Wylie DE: Evidence supporting the requirement for two proline residues for expression of c. Transfusion 40:321-324, 2000
42. Faas BHW, Beuling EA, Ligthart PC: Partial expression of Rhesus c on the Rhesus D polypeptide. Transfusion 41:1136-1142, 2001
43. Smythe JS, Anstee DJ: Expression of C antigen in transduced K562 cells. Transfusion 41:24-30, 2001
44. Faas BH, Simsek S, Bleeker PM, et al: Rh E/e genotyping by allele-specific primer amplification. Blood 85:829-832, 1995
45. Le Van Kim C, Mouro I, Brossard Y, et al: PCR-based determination of Rhc and RhE status of fetuses at risk of Rhc and RhE haemolytic disease. Br J Haematol 88:193-195, 1994
46. Avent ND: Antenatal genotyping of the blood groups of the fetus. Vox Sang 74:365-374, 1998 (suppl)
47. Faas BH, Maaskant-Van Wijk PA, von dem Borne AE, et al: The applicability of different PCR-based methods for fetal RHD and K1 genotyping: A prospective study. Prenat Diagn 20:453-458, 2000
48. Faas BHW, Beckers EAM, Wildoer P, et al: Molecular background of VS and weak C expression in blacks. Transfusion 37:38-44, 1997
49. Spence WC, Potter P, Maddalena A, et al: DNA-based prenatal determination of the RhEe genotype. Obstet Gynecol 86:670-672, 1995
50. Geifman-Holtzman O, Bernstein IM, Berry SM, et al: Rapid molecular determination of fetal rhesus E type. Prenat Diagn 16:489-493, 1996
51. Yankowitz J, Li S, Weiner CP: Polymerase chain reaction determination of RhC, Rhc, and RhE blood types: An evaluation of accuracy and clinical utility. Am J Obstet Gynecol 176:1107-1111, 1997
52. Lee S, Lin M, Mele A, et al: Proteolytic processing of big endothelin-3 by the kell blood group protein. Blood 94:1440-1450, 1999
53. Bowman JM, Pollock JM, Manning FA, et al: Maternal Kell blood group alloimmunization. Obstet Gynecol 79:239-244, 1992
54. Lee S, Wu X, Reid M, et al: Molecular basis of the Kell (K1) phenotype. Blood 85:912-916, 1995
55. Vaughan JI, Manning M, Warwick RM, et al: Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med 338:798-803, 1998
56. Wagner T, Berer A, Lanzer G, et al: Kell is not restricted to the erythropoietic lineage but is also expressed on myeloid progenitor cells. Br J Haematol 110:409-411, 2000
57. Wagner T, Bernaschek G, Geissler K: Inhibition of megakaryopoiesis by Kell-related antibodies. N Engl J Med 343:72, 2000
58. Lee S, Bennett PR, Overton T, et al: Prenatal diagnosis of Kell blood group genotypes: KEL1 and KEL2. Am J Obstet Gynecol 175:455-459, 1996
59. Hessner MJ, McFarland JG, Endean DJ: Genotyping of KEL1 and KEL2 of the human Kell blood group system by the polymerase chain reaction with sequence-specific primers. Transfusion 36:495-499, 1996
60. Murphy MT, Fraser RH, Goddard JP: Development of a PCR-based diagnostic assay for the determination of KEL genotype in donor blood samples. Transfus Med 6:133-137, 1996
61. Avent ND, Martin PG: Kell typing by allele-specific PCR (ASP). Br J Haematol 93:728-730, 1996
62. Lighten AD, Overton TG, Sepulveda W, et al: Accuracy of prenatal determination of RhD type status by polymerase chain reaction with amniotic cells. Am J Obstet Gynecol 173:1182-1185, 1995
63. Fisk NM, Bennett P, Warwick RM, et al: Clinical utility of fetal RhD typing in alloimmunized pregnancies by means of polymerase chain reaction on amniocytes or chorionic villi. Am J Obstet Gynecol 171:50-54, 1994
64. Rossiter JP, Blakemore KJ, Kickler TS, et al: The use of polymerase chain reaction to determine fetal RhD status. Am J Obstet Gynecol 171:1047-1051, 1994
65. Van Den Veyver IB, Subramanian SB, Hudson KM, et al: Prenatal diagnosis of the RhD fetal blood type on amniotic fluid by polymerase chain reaction. Obstet Gynecol 87:419-422, 1996
66. Crombach G, Picard F, Beckmann M, et al: Fetal Rhesus D genotyping on amniocytes in alloimmunised pregnancies using fluorescence duplex polymerase chain reaction. Br J Obstet Gynaecol 104:15-19, 1997
67. Heckerling PS, Verp MS: Amniocentesis or chorionic villus sampling for prenatal genetic testing: A decision analysis. J Clin Epidemiol 44:457-470, 1991
68. Schmorl G: Pathologisch-anatomische Untersuchungen Ueber Publereklampsie. Vogel, Leipzig, 1893
69. Bianchi DW: Fetal cells in the maternal circulation: Feasibility for prenatal diagnosis. Br J Haematol 105:574-583, 1999
70. Lo YM, Patel P, Wainscoat JS, et al: Prenatal sex determination by DNA amplification from maternal peripheral blood. Lancet 2:1363-1365, 1989
71. Lo YM, Bowell PJ, Selinger M, et al: Prenatal determination of fetal RhD status by analysis of peripheral blood of rhesus negative mothers. Lancet 341:1147-1148, 1993
72. Lo YM, Noakes L, Bowell PJ, et al: Detection of fetal RhD sequence from peripheral blood of sensitized RhD-negative pregnant women. Br J Haematol 87:658-660, 1994
73. Geifman-Holtzman O, Bernstein IM, Berry SM, et al: Fetal RhD genotyping in fetal cells flow sorted from maternal blood. Am J Obstet Gynecol 174:818-822, 1996
74. Sekizawa A, Watanabe A, Kimura T, et al: Prenatal diagnosis of the fetal RhD blood type using a single fetal nucleated erythrocyte from maternal blood. Obstet Gynecol 87:501-505, 1996
75. Hamlington J, Cunningham J, Mason G, et al: Prenatal detection of rhesus D genotype. Lancet 349:540, 1997
76. Bianchi DW, Williams JM, Sullivan LM, et al: PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies. Am J Hum Genet 61:822-829, 1997
77. Bianchi DW, Zickwolf GK, Weil GJ, et al: Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A 93:705-708, 1996
78. van Wijk IJ, van Vugt JM, Mulders MA, et al: Enrichment of fetal trophoblast cells from the maternal peripheral blood followed by detection of fetal deoxyribonucleic acid with a nested X/Y polymerase chain reaction. Am J Obstet Gynecol 174:871-878, 1996
79. Sargent IL, Johansen M, Chua S, et al: Clinical experience: Isolating trophoblasts from maternal blood. Ann N Y Acad Sci 731:154-161, 1994
80. Slunga-Tallberg A, el-Rifai W, Keinanen M, et al: Maternal origin of nucleated erythrocytes in peripheral venous blood of pregnant women. Hum Genet 96:53-57, 1995
81. Mesker WE, Ouwerkerk-van Velzen MC, Oosterwijk JC, et al: Two-colour immunocytochemical staining of gamma (gamma) and epsilon (epsilon) type haemoglobin in fetal red cells. Prenat Diagn 18:1131-1137, 1998
82. Zheng YL, Demaria M, Zhen D, et al: Flow sorting of fetal erythroblasts using intracytoplasmic anti-fetal haemoglobin: Preliminary observations on maternal samples. Prenat Diagn 15:897-905, 1995
83. Jansen MW, Brandenburg H, Wildschut HI, et al: The effect of chorionic villus sampling on the number of fetal cells isolated from maternal blood and on maternal serum alpha-fetoprotein levels. Prenat Diagn 17:953-959, 1997
84. Al-Mufti R, Howard C, Overton T, et al: Detection of fetal messenger ribonucleic acid in maternal blood to determine fetal RhD status as a strategy for noninvasive prenatal diagnosis. Am J Obstet Gynecol 179:210-214, 1998
85. Cunningham J, Yates Z, Hamlington J, et al: Non-invasive RNA-based determination of fetal Rhesus D type: A prospective study based on 96 pregnancies. Br J Obstet Gynaecol 106:1023-1028, 1999
86. Nawroz H, Koch W, Anker P, et al: Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med 2:1035-1037, 1996
87. Chen XQ, Stroun M, Magnenat JL, et al: Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med 2:1033-1035, 1996
88. Lo YM, Corbetta N, Chamberlain PF, et al: Presence of fetal DNA in maternal plasma and serum. Lancet 350:485-487, 1997
89. Lo YM, Tein MS, Lau TK, et al: Quantitative analysis of fetal DNA in maternal plasma and serum: Implications for noninvasive prenatal diagnosis. Am J Hum Genet 62:768-775, 1998
90. Leung TN, Zhang J, Lau TK, et al: Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. Clin Chem 47:137-139, 2001
91. Lo YM, Lau TK, Zhang J, et al: Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21. Clin Chem 45:1747-1751, 1999
92. Zhong XY, Burk MR, Troeger C, et al: Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses. Prenat Diagn 20:795-798, 2000
93. Chiu RW, Poon LL, Lau TK, et al: Effects of bloodprocessing protocols on fetal and total DNA quantification in maternal plasma. Clin Chem 47:1607-1613, 2001
94. Sekizawa A, Samura O, Zhen DK, et al: Apoptosis in fetal nucleated erythrocytes circulating in maternal blood. Prenat Diagn 20:886-889, 2000
95. van Wijk IJ, de Hoon AC, Jurhawan R, et al: Detection of apoptotic fetal cells in plasma of pregnant women. Clin Chem 46:729-731, 2000
96. Lo YM, Zhang J, Leung TN, et al: Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 64:218-224, 1999
97. Bianchi DW: Fetal DNA in maternal plasma: The plot thickens and the placental barrier thins. Am J Hum Genet 62:763-764, 1998
98. Poon LL, Lo YM: Circulating fetal DNA in maternal plasma. Clin Chim Acta 313:151-155, 2001
99. Hahn S, Zhong XY, Burk MR, et al: Both maternal and fetal cell-free DNA in plasma fluctuate. Ann N Y Acad Sci 945:141-144, 2001
100. Rijnders RJ, van der Schoot CE, Bossers B, et al: Fetal sex determination from maternal plasma in pregnancies at risk for congenital adrenal hyperplasia. Obstet Gynecol 98:374-378, 2001
101. Amicucci P, Gennarelli M, Novelli G, et al: Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma. Clin Chem 46:301-302, 2000
102. Saito H, Sekizawa A, Morimoto T, et al: Prenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet 356:1170, 2000
103. Skinner J, Luettich K, Ring M, et al: Fetal DNA in maternal circulation of first-trimester spontaneous abortions. Obstet Gynecol 97:460-463, 2001
104. Al-Yatama MK, Mustafa AS, Ali S, et al: Detection of Y chromosome-specific DNA in the plasma and urine of pregnant women using nested polymerase chain reaction. Prenat Diagn 21:399-402, 2001
105. Wei C, Saller DN, Sutherland JW: Detection and quantification by homogeneous PCR of cell-free fetal DNA in maternal plasma. Clin Chem 47:336-338, 2001
106. Costa JM, Benachi A, Gautier E, et al: First-trimester fetal sex determination in maternal serum using real-time PCR. Prenat Diagn 21:1070-1074, 2001
107. Ohashi Y, Miharu N, Honda H, et al: Quantitation of fetal DNA in maternal serum in normal and aneuploid prenancies. Hum Genet 108:123-127, 2001
108. Honda H, Miharu N, Ohashi Y, et al: Successful diagnosis of fetal gender using conventional PCR analysis of maternal serum. Clin Chem 47:41-46, 2001
109. Faas BH, Beuling EA, Christiaens GC, et al: Detection of fetal RHD-specific sequences in maternal plasma. Lancet 352:1196-1197, 1998
110. Lo YM, Hjelm NM, Fidler C, et al: Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 339:1734-1738, 1998
111. Rouilllac C, Puillandre P, Colin Y, et al: Fetal RHD typing using DNA isolated from maternal plasma: A prediagnosis study on 182 cases. Vox Sang 78:O026, 2000 (suppl. abstr)
112. Zhong XY, Holzgreve W, Hahn S: Detection of fetal Rhesus D and sex using fetal DNA from maternal plasma by multiplex polymerase chain reaction. BJOG 107:766-769, 2000
113. Bischoff FZ, Nguyen DD, Marquez-Do D, et al: Noninvasive determination of fetal RhD status using fetal DNA in maternal serum and PCR. J Soc Gynecol Investig 6:64-69, 1999
114. Lacey PA, Caskey CR, Werner DJ, et al: Fatal hemolytic disease of a newborn due to anti-D in an Rh-positive Du variant mother. Transfusion 23:91-94, 1998
115. Thiede C, Bornhauser M, Oelschlagel U, et al: Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers. Leukemia 15:293-302, 2001
116. Pertl B, Sekizawa A, Samura O, et al: Detection of male and female fetal DNA in maternal plasma by multiplex fluorescent polymerase chain reaction amplification of short tandem repeats. Hum Genet 106:45-49, 2000
117. Tang NL, Leung TN, Zhang J, et al: Detection of fetal-derived paternally inherited X-chromosome polymorphisms in maternal plasma. Clin Chem 45:2033-2035, 1999
118. Finning KM, Martin PG, Soothill P, et al: Non-invasive prenatal diagnosis of fetal blood group status. Transfus Med 9:23, 1999 (abstr)
119. Vervoordeldonk SF, Doumaid K, Remmerswaal EB, et al: Long-term detection of microchimaerism in peripheral blood after pretransplantation blood transfusion. Br J Haematol 102:1004-1009, 1998